Factors such as increasing access to health information, the introduction of new medical treatments and technologies and the spike in birth rate are increasing the need for payers in the pharmaceutical industry. Payers ensure the delivery of the best possible health outcomes to the patients from their financial plan.
Finding the top payers in the pharmaceutical industry
Pharmaceutical Technology has listed the leading payers in pharma based on its intel, insights, and decades-long experience in the sector. The list includes companies that provide a range of services, including but not limited to:
· New product/health plan innovation research
· Concept evaluation testing
· Competitive intelligence studies
· Marketing trend analysis
· Voice of customer studies
· Pricing research
· Buying behaviour analysis
· Brand health studies
· Brand usage studies
· Media habits
· Benchmarking studies
· Patient education programmes regarding the administration of medications and therapies
· Identifying available financial resources
· Programmes for treatment adherence and monitoring therapy compliance, and
· Documentation for a faster drug authorisation process
The information in the download document is intended for executives, manufacturers, distributors, suppliers, technicians, research scientists, product development scientists, and other individuals involved in the pharmaceutical industry.
The document contains detailed information on the suppliers and their product offerings, alongside their contact details to aid your purchasing or hiring decision.
Who are the payers in the pharmaceutical industry?
Payers in the pharmaceutical industry such as health plan providers and Medicaid are the bodies or organisations other than the patient that finance or reimburse health services and medical product expenses.
Payers in pharma can be categorised broadly into three types based on their functionality – national payers, regional payers and local payers.
National payers review the product to determine the price or reimbursement of products. Regional payers review the product depending on the impact of the product on the region. Local payers, who may be within hospitals, such as formulary committee members, understand the direct impact of the product on the hospital budget and the benefit to their patients.